PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

A new twist on neuro disease: Discovery could aid people with dystonia, Parkinson's and more

Persistence pays off with new mouse model of primary dystonia

2014-06-18
(Press-News.org) ANN ARBOR, Mich. -- Twist and hold your neck to the left. Now down, and over to the right, until it hurts. Now imagine your neck – or arms or legs – randomly doing that on their own, without you controlling it.

That's a taste of what children and adults with a neurological condition called dystonia live with every day – uncontrollable twisting and stiffening of neck and limb muscles.

The mystery of why this happens, and what can prevent or treat it, has long puzzled doctors, who have struggled to help their suffering dystonia patients. Now, new re-search from a University of Michigan Medical School team may finally open the door to answering those questions and developing new options for patients.

In a new paper in the Journal of Clinical Investigation, the researchers describe new strains of mice they've developed that almost perfectly mimic a human form of the disease. They also detail new discoveries about the basic biology of dystonia, made from studying the mice.

They'll soon make the mice available for researchers everywhere to study, to accelerate understanding of all forms of dystonia and the search for better treatments. The lack of such mice has held back research on dystonia for years.

The U-M team's success in creating a mouse model for the disease came only after 17 years of stubborn, persistent effort – often in the face of setbacks and failure.

Led by U-M neurologist William Dauer, M.D., the team tried to figure out how and why a gene defect leads to an inherited form of dystonia that, intriguingly, doesn't start until the pre-teen or teen years, after which it progresses for many years but then stops getting worse after the person reaches their mid-20s.

The gene defect responsible, called DYT1, causes brain cells to make a less-active form of a protein called torsinA. But despite more than a decade of effort by Dauer's team and many others around the world, no one has been able to translate this information into an animal model with dystonia's characteristic movements.

Using the childhood onset as a clue, Dauer and his team used cutting-edge genetic technology to severely impair torsinA function during early brain development. This novel twist caused the new mice to closely mimic the human disease: they don't develop dystonia until they reach preteen age in "mouse years," and their symptoms stop getting worse after a while.

With this powerful tool in hand, Dauer's team were now able to peer into the brains of these animals to begin to unravel the mysteries of the disease.

In an unexpected development, they found that the lack of torsinA in the brains of dystonic mice led to the death of neurons – a process called neurodegeneration – in just a few highly localized parts of the brain that control movement. Like the dystonic movements, this neurodegeneration began in young mice, progressed for a time, and then became fixed.

"We've created a model for understanding why certain parts of the brain are more vulnerable to prob-lems from a certain genetic insult," says Dauer, an associate professor in the U-M departments of Neu-rology and Cell & Developmental Biology. "In this case, we're showing that in dystonia, the lack of this particular protein during a critical window of time is causing cell death. Every disease is telling us something about biology -- one just has to listen carefully."

More discoveries to come

Dauer and his team don't yet know why only one-third of human DYT1 gene mutation carriers develop primary dystonia during their school years, and why those who don't develop the disease before their early 20s will never go on to develop it.

They believe some critical events during the brain's development in infancy and childhood may have to do with it - and they're already working to explore that question in mice.

They also believe their mouse model will help them and other researchers understand how dystonia occurs in people who have Parkinson's disease, Huntington's disease, or damage caused by a stroke or brain injury. Some people develop dystonia without either a known gene defect or any of these other diagnoses – a condition called idiopathic dystonia.

In all these cases, as in people with DYT1 mutations, dystonia's twisting and curling motions likely arise from problems in the area of the brain that controls the body's motor control system.

In other words, something's going wrong in the process of sending signals to the nerves that control muscles involved in movement. Studying a "pure" form of dystonia using the mice will allow researchers to understand just what's going on.

The team's ultimate goal is to find new treatments for all kinds of dystonia. Currently, children, teens and young adults who develop it can take medications or even opt for a form of neurosurgery called deep brain stimulation. But the drugs carry major side effects and are only partially effective – and brain surgery carries its own risks. Dauer and his team are working to screen drug candidates.

INFORMATION: In addition to Dauer, the research team included first author Chun-Chi Liang, and laboratory members Lauren M. Tanabe, Stephanie Jou, and Frank Chi.

Patients interested in learning more about dystonia care at the U-M Health System should visit http://www.uofmhealth.org/medical-services/dystonia .

Funding: The research was funded by the Bachmann-Strauss Dystonia and Parkinson Disease Foun-dation, the Robert P. Apkarian Integrated Electron Microscopy Core of Emory University, and a grant from the National Institute of Neurological Disorders and Stroke, NS077730.

Reference: Journal of Clinical Investigation, Volume 124 Number 7, July 2014 doi:10.1172/JCI72830


ELSE PRESS RELEASES FROM THIS DATE:

Stress hormone linked to short-term memory loss as we age

2014-06-18
A new study at the University of Iowa reports a potential link between stress hormones and short-term memory loss in older adults. The study, published in the Journal of Neuroscience, reveals that having high levels of cortisol—a natural hormone in our body whose levels surge when we are stressed—can lead to memory lapses as we age. Short-term increases in cortisol are critical for survival. They promote coping and help us respond to life's challenges by making us more alert and able to think on our feet. But abnormally high or prolonged spikes in cortisol—like what ...

Kidney problems may prevent heart attack patients from receiving life-saving care

2014-06-18
Heart attack patients with kidney problems may not be getting the full treatment they need, according to a new study led by King's College London. The study found that patients admitted to hospital with chest pains and poorly functioning kidneys are less likely to be given an angiogram and early invasive treatment, which might increase their chance of surviving a heart attack. People admitted to hospital with a suspected heart attack are normally offered early angiography or X-ray of their heart – a procedure recommended in UK, European and US healthcare guidelines regardless ...

What amino acids in shells can tell us about Bronze Age people

2014-06-18
A new study by scientists at the University of York has shed new light on the use of mollusc shells as personal adornments by Bronze Age people. The research team used amino acid racemisation analysis (a technique used previously mainly for dating artefacts), light microscopy, scanning electron microscopy and Raman spectroscopy, to identify the raw materials used to make beads in a complex necklace discovered at an Early Bronze Age burial site at Great Cornard in Suffolk, UK. They discovered that Bronze Age craftspeople used species like dog whelk and tusk shells, both ...

Brain imaging shows enhanced executive brain function in people with musical training

Brain imaging shows enhanced executive brain function in people with musical training
2014-06-18
BOSTON (June 17, 2014)—A controlled study using functional MRI brain imaging reveals a possible biological link between early musical training and improved executive functioning in both children and adults, report researchers at Boston Children's Hospital. The study, appearing online June 17 in the journal PLOS ONE, uses functional MRI of brain areas associated with executive function, adjusting for socioeconomic factors. Executive functions are the high-level cognitive processes that enable people to quickly process and retain information, regulate their behaviors, make ...

Stress hormone elevation is associated with working memory deficits in aging

2014-06-18
Washington, DC — A new study published in the June 18 issue of The Journal of Neuroscience adds to a body of evidence suggesting stress may accelerate cognitive decline later in life. The study found that aged rats with high levels of the stress hormone corticosterone showed structural changes in the brain and short-term memory deficits. While most people will experience some cognitive decline as they get older, the extent of these changes and how rapidly they progress varies greatly from one person to the next. Scientists are interested in understanding the factors ...

Penn Medicine study shows 'clot-busting' drugs reduce deaths from pulmonary embolism by nearly half

Penn Medicine study shows clot-busting drugs reduce deaths from pulmonary embolism by nearly half
2014-06-17
PHILADELPHIA - Bringing clarity to a decades-long debate, a national team of researchers led by experts from the Perelman School of Medicine at the University of Pennsylvania has found that adding clot-busting medications known as thrombolytics to conventional approaches when treating sudden-onset pulmonary embolism patients is associated with 47 percent fewer deaths than using standard intravenous or under-the-skin anticoagulant medications alone. A pulmonary embolism is a blockage of one or more arteries in the lungs, primarily because of blood clots that travel there ...

Analysis finds mixed results for use of thrombolytic therapy for blood clot in lungs

2014-06-17
In an analysis that included data from 16 trials performed over the last 45 years, among patients with pulmonary embolism, receipt of therapy to dissolve the blood clot (thrombolysis) was associated with lower rates of death, but increased risks of major bleeding and intracranial hemorrhage, according to a study in the June 18 issue of JAMA. The authors note that these findings may not apply to patients with low-risk pulmonary embolism. Pulmonary embolism (PE; a blockage of the main artery of the lung or one of its branches) is an important cause of illness and death, ...

Survey suggests that self-reported health of young adults has improved

2014-06-17
Findings of a large survey indicate that since 2010, when young adults could be covered under their parents' health insurance plans until age 26, self-reported health among this group has improved, along with a decrease in out-of-pocket health care expenditures, according to a study in the June 18 issue of JAMA. Beginning September 23, 2010, the Affordable Care Act allowed young adults to be covered under their parents' plans until 26 years of age. This dependent coverage provision increased insurance coverage and access among young adults. However, little is known about ...

TNF inhibitors for treatment of bowel disease not linked with increased risk of cancer

2014-06-17
In a study that included more than 56,000 patients with inflammatory bowel disease, use of a popular class of medications known as tumor necrosis factor alpha antagonists was not associated with an increased risk of cancer over a median follow-up of 3.7 years, although an increased risk of malignancy in the long term, or with increasing number of doses, cannot be excluded, according to a study in the June 18 issue of JAMA. Tumor necrosis factor α (TNF-α) antagonists are drugs that have been shown to be beneficial in reducing the inflammation in inflammatory ...

Study compares survival for treatments of uncommon eye cancer

2014-06-17
In patients with advanced uveal melanoma, treatment with the agent selumetinib, compared with chemotherapy, resulted in an improved cancer progression-free survival time and tumor response rate, but no improvement in overall survival, according to a study in the June 18 issue of JAMA. The modest improvement in clinical outcomes was accompanied by a high rate of adverse events. Uveal melanoma arises from melanocytes within the choroid layer of the eye. There are about 1,500 new cases of uveal melanoma per year in the U.S., which is biologically distinct from skin related ...

LAST 30 PRESS RELEASES:

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

The experts that can outsmart optical illusions

Pregnancy may reduce long COVID risk

Scientists uncover novel immune mechanism in wheat tandem kinase

Three University of Virginia Engineering faculty elected as AAAS Fellows

[Press-News.org] A new twist on neuro disease: Discovery could aid people with dystonia, Parkinson's and more
Persistence pays off with new mouse model of primary dystonia